Canine Immune Mediated Thrombocytopenia

Susan Holt, Isabell Riley

Research output: Contribution to journalJournal Articlepeer-review

810 Downloads (Pure)


Immune-mediated thrombocytopenia (IMT) is a common disease in dogs. Primary IMT is idiopathic, while secondary IMT can result from a variety of infectious agents or some treatments. Symptoms may include lethargy, anorexia and mild pyrexia, together with a low platelet count and associated bleeding disorders. Prognosis is generally positive, but reduced with presence of melena or raised blood urea nitrogen. Treatment will include some form of immunosuppressive therapy, such as prednisolone, which can have multiple side effects. Nursing the IMT patient will aim at monitoring and reducing spontaneous haemorrhage and managing treatment side effects. To ensure owner understanding and compliance, it is vital to discuss these side effects and any appropriate home adjustments so an achievable plan can be developed for home care.
Original languageEnglish
Pages (from-to)264-269
Number of pages6
JournalThe Veterinary Nurse
Issue number5
Early online date21 Jun 2019
Publication statusPublished - Jun 2019


  • canine immune-mediated thrombocytopenia
  • platelet count
  • veterinary nursing
  • immunosuppressive therapy


Dive into the research topics of 'Canine Immune Mediated Thrombocytopenia'. Together they form a unique fingerprint.

Cite this